SCHEMBL483180

SCHEMBL483180

C1=C2CNCN2CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29689430 0.98
Phenol SCHEMBL29688819 0.85 CA12 (0.34)
SCHEMBL436647 0.81 CHRNB2 (0.33)
SCHEMBL3810433 0.81 HTR2C (0.40)
SCHEMBL1300630 0.78
SCHEMBL30579615 0.68 HTR2C (0.34)
SCHEMBL860227 0.67 HRH1 (0.41)
SCHEMBL1000578 0.67
SCHEMBL1174158 0.65
SCHEMBL368150 0.65 MAPT (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 234 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118745244-A Method for preparing polycarbonate by proton type ionic liquid catalysis 中国科学院过程工程研究所 2024-10-08 CN claimed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP claimed
US-20200407508-A1 METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2020-12-31 US claimed
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 EP claimed
EP-2130827-B1 METHOD FOR PRODUCING QUINOLONE CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2012-02-01 EP claimed
EP-1711472-B1 MEHTOD FOR PRODUCING IONIC LIQUIDS BASF SE (DE) 2011-05-25 EP claimed
US-7875722-B2 having high antibacterial activity and high safety, at high yield and in a simple manner; one-pot process DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-01-25 US claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
EP-1644395-B1 PROCESSES FOR PREPARING 4'AZIDO NUCLEOSIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-22 EP claimed
US-7087778-B2 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-08 US claimed
WO-2005118527-A2 FLUOROUS CAPPING REAGENTS, AND METHODS FOR PEPTIDE PURIFICATION TRUSTEES OF TUFTS COLLEGE (US) 2005-12-15 WO claimed
US-20050027119-A1 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. 2005-02-03 US claimed
EP-1363890-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2003-11-26 EP claimed
WO-2002062766-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-08-15 WO claimed
EP-1211254-A1 PROCESS FOR THE PREPARATION OF BENZOXAZINE DERIVATIVES AND INTERMEDIATES THEREFOR DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-06-05 EP claimed
EP-1204645-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2002-05-15 EP claimed
WO-2001010842-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2001-02-15 WO claimed
US-4889911-A ESTERIFICATION, ESTER INTERCHANGE; CATALYSIS WITH HETEROCYCLIC NITROGEN COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1989-12-26 US claimed
EP-0303931-A2 Process for the fabrication of thermotropic, wholly aromatic polyesters and polyestercarbonates BAYER AG (DE) 1989-02-22 EP claimed
US-12630744-B2 Polishing compositions and methods of use thereof FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2026-05-19 US disclosed
EP-4688987-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM Electronic Materials U.S.A, Inc. (US) 2026-02-11 EP disclosed
US-20260015438-A1 Photopolymerizable Compositions Including a Polyurethane Methacrylate Polymer Prepared Using a Polycarbonate Diol, Articles, and Methods SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-01-15 US disclosed
EP-3917445-B1 METHODS OF MAKING AND POSTPROCESSING ORTHODONTIC ARTICLES SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-11-05 EP disclosed
US-12440560-B2 Substituted pyrimidines as vaccine adjuvants Sumitomo Pharma Co., Ltd. (JP) 2025-10-14 US disclosed
EP-3603619-B1 VACCINE ADJUVANT FORMULATION SUMITOMO PHARMA CO LTD (JP) 2025-08-13 EP disclosed
US-12351668-B2 Orthodontic articles comprising polymerized composition with pendent cyclic moieties, methods, and polymerizable compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-07-08 US disclosed
EP-3973007-B1 ORTHODONTIC ARTICLES COMPRISING POLYMERIZED COMPOSITION WITH PENDENT CYCLIC MOIETIES, METHODS, AND POLYMERIZABLE COMPOSITIONS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-25 EP disclosed
US-12297316-B2 Orthodontic articles prepared using a polycarbonate diol, polymerizable compositions, and methods of making the articles SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-05-13 US disclosed
CN-119219534-B Synthesis method and application of o-amino disulfide and benazolin ethyl ester key intermediate 4-chlorobenzothiazole 鄂尔多斯应用技术学院 2025-04-08 CN disclosed
WO-2025057020-A1 PHOTOPOLYMERIZABLE COMPOSITIONS INCLUDING UREA/ACRYLAMIDE FUNCTIONAL COMPONENT, ARTICLES AND METHODS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-03-20 WO disclosed
US-20250009479-A1 Orthodontic Articles and Methods of Making and Postprocessing Same SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-01-09 US disclosed
CN-119219534-A Synthesis method and application of o-amino disulfide and benazolin ethyl ester key intermediate 4-chlorobenzothiazole 鄂尔多斯应用技术学院 2024-12-31 CN disclosed
US-12121413-B2 Orthodontic articles and methods of making and postprocessing same SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-10-22 US disclosed
US-20240327675-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2024-10-03 US disclosed
WO-2024206301-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2024-10-03 WO disclosed
CN-110650729-B Vaccine adjuvant formulations 住友制药株式会社 2024-08-20 CN disclosed
US-20240270893-A1 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, POLYMERIZABLE COMPOSITIONS, AND METHODS OF MAKING THE ARTICLES SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2024-08-15 US disclosed
US-20240245766-A1 PYRIMIDINE COMPOUND Sumitomo Pharma Co., Ltd. (JP) 2024-07-25 US disclosed
WO-2024118398-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2024-06-06 WO disclosed
US-20240174892-A1 POLISHING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2024-05-30 US disclosed
US-11945900-B2 Orthodontic articles prepared using a polycarbonate diol, polymerizable compositions, and methods of making the articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-04-02 US disclosed
US-11911466-B2 Substituted pyrimidines as vaccine adjuvants Sumitomo Pharma Co., Ltd. (JP) 2024-02-27 US disclosed
US-11833247-B2 Vaccine adjuvant formulation Sumitomo Pharma Co., Ltd. (JP) 2023-12-05 US disclosed
US-20230322966-A1 Photopolymerizable Compositions Including a Polyurethane Methacrylate Polymer Prepared Using a Polycarbonate Diol, Articles, and Methods SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2023-10-12 US disclosed
US-11771086-B2 Pest control composition including novel iminopyridine derivative MMAG CO., LTD. (JP) 2023-10-03 US disclosed
EP-3868741-B1 COMPOSITION COMPRISING A PYRIMIDINE COMPOUND AND A PATHOGEN DERIVED ANTIGEN SUMITOMO PHARMA CO LTD (JP) 2023-08-30 EP disclosed
US-11708428-B2 Photopolymerizable compositions including a polyurethane methacrylate polymer prepared using a polycarbonate diol, articles, and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-07-25 US disclosed
US-11584874-B2 Increased saturation of ice melting compositions and methods of use BASF SE (DE) 2023-02-21 US disclosed
US-20220273563-A1 VACCINE ADJUVANT FORMULATION Sumitomo Pharma Co., Ltd. (JP) 2022-09-01 US disclosed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP disclosed
US-20220242991-A1 Orthodontic Articles Comprising Polymerized Composition with Pendent Cyclic Moieties, Methods, and Polymerizable Compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-08-04 US disclosed
US-20220226468-A1 PYRIMIDINE COMPOUND Sumitomo Pharma Co., Ltd. (JP) 2022-07-21 US disclosed
CN-111771885-B Pest control composition comprising novel iminopyridine derivatives 株式会社MMAG 2022-05-17 CN disclosed
CN-112244015-B Pest control composition comprising novel iminopyridine derivatives 株式会社MMAG 2022-05-17 CN disclosed
EP-3973007-A1 ORTHODONTIC ARTICLES COMPRISING POLYMERIZED COMPOSITION WITH PENDENT CYCLIC MOIETIES, METHODS, AND POLYMERIZABLE COMPOSITIONS 3M Innovative Properties Company (US) 2022-03-30 EP disclosed
US-20220056258-A1 ORTHODONTIC ARTICLES COMPRISING POLYESTER URETHANE (METH)ACRYLATE POLYMER AND MONOFUNCTIONAL (METH)ACRYLATE MONOMER, METHODS, AND POLYMERIZABLE COMPOSITIONS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-02-24 US disclosed
US-11253476-B2 Vaccine adjuvant formulation SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-02-22 US disclosed
US-20220023007-A1 Orthodontic Articles and Methods of Making and Postprocessing Same SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2022-01-27 US disclosed
US-11225535-B2 Photopolymerizable compositions including a polyurethane methacrylate polymer prepared using a polycarbonate diol, articles, and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-01-18 US disclosed
EP-3917445-A1 ORTHODONTIC ARTICLES AND METHODS OF MAKING AND POSTPROCESSING SAME 3M Innovative Properties Company (US) 2021-12-08 EP disclosed
CN-112118802-B Orthodontic articles prepared using polycarbonate diols and methods of making the same 3M创新有限公司 2021-12-07 CN disclosed
CN-113767131-A Orthodontic articles, methods, and polymerizable compositions comprising polymeric compositions having pendant ring moieties 3M创新有限公司 2021-12-07 CN disclosed
US-20210361389-A1 HYDRATED ORTHODONTIC ARTICLES, KITS, AND METHODS OF MAKING SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-11-25 US disclosed
US-20210355262-A1 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, AND METHODS OF MAKING SAME 3M INNOVATIVE PROPERTIES COMPANY 2021-11-18 US disclosed
US-20210301042-A1 PHOTOPOLYMERIZABLE COMPOSITIONS INCLUDING A POLYURETHANE METHACRYLATE POLYMER PREPARED USING A POLYCARBONATE DIOL, ARTICLES, AND METHODS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2021-09-30 US disclosed
EP-3883521-A1 ORTHODONTIC ARTICLES COMPRISING POLYESTER URETHANE (METH)ACRYLATE POLYMER AND MONOFUNCTIONAL (METH)ACRYLATE MONOMER, METHODS, AND POLYMERIZABLE COMPOSITIONS 3M Innovative Properties Company (US) 2021-09-29 EP disclosed
CN-113286560-A Orthodontic articles and methods of making and post-treating the same 3M创新有限公司 2021-08-20 CN disclosed
CN-113015511-A Orthodontic articles, methods, and polymerizable compositions comprising polyester urethane (meth) acrylate polymers and monofunctional (meth) acrylate monomers 3M创新有限公司 2021-06-22 CN disclosed
US-20210171701-A1 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, POLYMERIZABLE COMPOSITIONS, AND METHODS OF MAKING THE ARTICLES SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2021-06-10 US disclosed
US-20210163664-A1 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, AND METHODS OF MAKING SAME SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2021-06-03 US disclosed
EP-3813764-A2 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, POLYMERIZABLE COMPOSITIONS, AND METHODS OF MAKING THE ARTICLES 3M Innovative Properties Company (US) 2021-05-05 EP disclosed
EP-3360864-B1 PYRIMIDINE COMPOUND SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2021-04-28 EP disclosed
EP-3806774-A1 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, AND METHODS OF MAKING SAME 3M Innovative Properties Company (US) 2021-04-21 EP disclosed
US-20210095056-A1 PHOTOPOLYMERIZABLE COMPOSITIONS INCLUDING A POLYURETHANE METHACRYLATE POLYMER PREPARED USING A POLYCARBONATE DIOL, ARTICLES, AND METHODS SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2021-04-01 US disclosed
WO-2021037349-A1 MULTI-COMPONENT CROSSLINKABLE MATERIALS BASED ON ORGANYLOXYSILANE-TERMINATED POLYMERS AND EPOXY-FUNCTIONAL COMPOUNDS WACKER CHEMIE AG (DE) 2021-03-04 WO disclosed
CN-112384188-A Orthodontic articles made using polycarbonate diols, polymerizable compositions, and methods of making articles 3M创新有限公司 2021-02-19 CN disclosed
US-20210008197-A1 PYRIMIDINE COMPOUND SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-01-14 US disclosed
US-20200407508-A1 METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) BASF SE (DE) 2020-12-31 US disclosed
EP-3752123-A1 PHOTOPOLYMERIZABLE COMPOSITIONS INCLUDING A POLYURETHANE METHACRYLATE POLYMER PREPARED USING A POLYCARBONATE DIOL, ARTICLES, AND METHODS 3M Innovative Properties Company (US) 2020-12-23 EP disclosed
CN-112118802-A Orthodontic articles prepared using polycarbonate diols and methods of making the same 3M创新有限公司 2020-12-22 CN disclosed
CN-112105332-A Photopolymerizable compositions, articles, and methods comprising urethane methacrylate polymers prepared using polycarbonate diols 3M创新有限公司 2020-12-18 CN disclosed
WO-2020234775-A1 ORTHODONTIC ARTICLES COMPRISING POLYMERIZED COMPOSITION WITH PENDENT CYCLIC MOIETIES, METHODS, AND POLYMERIZABLE COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-11-26 WO disclosed
EP-3740543-A1 INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE BASF SE (DE) 2020-11-25 EP disclosed
US-20200339851-A1 INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE BASF CORPORATION 2020-10-29 US disclosed
US-20200315172-A1 PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2020-10-08 US disclosed
US-10736319-B2 Pest control composition including novel iminopyridine derivative MEIJI SEIKA PHARMA CO., LTD. (JP) 2020-08-11 US disclosed
WO-2020157598-A1 ORTHODONTIC ARTICLES AND METHODS OF MAKING AND POSTPROCESSING SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-08-06 WO disclosed
EP-3355933-B1 ADENINE CONJUGATE COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2020-05-06 EP disclosed
US-10632192-B2 Pyrimidine compounds and their use as vaccine adjuvants SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-04-28 US disclosed
US-20200121600-A1 VACCINE ADJUVANT FORMULATION Sumitomo Pharma Co., Ltd. (JP) 2020-04-23 US disclosed
US-10597397-B2 Adenine conjugate compounds and their use as vaccine adjuvants SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-03-24 US disclosed
EP-3603619-A1 VACCINE ADJUVANT FORMULATION Sumitomo Dainippon Pharma Co., Ltd. (JP) 2020-02-05 EP disclosed
WO-2020003197-A2 ORTHODONTIC ARTICLES PREPARED USING A POLYCARBONATE DIOL, POLYMERIZABLE COMPOSITIONS, AND METHODS OF MAKING THE ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-01-02 WO disclosed
WO-2019141568-A1 INCREASED SATURATION OF ICE MELTING COMPOSITIONS AND METHODS OF USE BASF SE (DE) 2019-07-25 WO disclosed
US-10349655-B2 Pest control composition including novel iminopyridine derivative MEIJI SEIKA PHARMA CO., LTD. (JP) 2019-07-16 US disclosed
US-20190200610-A1 PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2019-07-04 US disclosed
US-20180280499-A1 PYRIMIDINE COMPOUND Sumitomo Pharma Co., Ltd. (JP) 2018-10-04 US disclosed
US-20180282334-A1 ADENINE CONJUGATE COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-10-04 US disclosed
EP-3355933-A1 ADENINE CONJUGATE COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS Sumitomo Dainippon Pharma Co., Ltd. (JP) 2018-08-08 EP disclosed
US-20180042233-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 2-IMINO GROUP AND PEST CONTROL AGENT INCLUDING THE SAME MEIJI SEIKA PHARMA CO., LTD. (JP) 2018-02-15 US disclosed
US-9758480-B2 1-(cycloalkyl-carbonyl)proline derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-09-12 US disclosed
US-9718840-B2 Condensed 5-oxazolidinone derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-08-01 US disclosed
EP-2980067-B1 PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2017-05-17 EP disclosed
EP-2634174-B1 Nitrogen-containing heterocyclic derivate having 2-imino group and pest control agent including the same MEIJI SEIKA PHARMA CO LTD (JP) 2017-05-17 EP disclosed
EP-2907390-B1 CONTROL AGENTS FOR HONEYBEE PARASITES AND CONTROL METHOD FOR HONEYBEE PARASITES USING SAME MEIJI SEIKA PHARMA CO LTD (JP) 2017-05-03 EP disclosed
US-20170022218-A1 CONDENSED 5-OXAZOLIDINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-01-26 US disclosed
EP-3095786-A1 CONDENSED 5-OXAZOLIDINONE DERIVATIVE Sumitomo Dainippon Pharma Co., Ltd. (JP) 2016-11-23 EP disclosed
US-9447118-B2 Preparation method of optically active diamine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-09-20 US disclosed
US-20160165888-A1 PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2016-06-16 US disclosed
EP-1732931-B1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL JANSSEN SCIENCES IRELAND UC (IE) 2016-05-18 EP disclosed
EP-1925611-B1 OPTICALLY ACTIVE DIAMINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME DAIICHI SANKYO CO LTD (JP) 2016-04-13 EP disclosed
US-9301525-B2 Pest control composition including novel iminopyridine derivative MEUI SEIKA PHARMA CO., LTD. (JP) 2016-04-05 US disclosed
EP-2980067-A1 PROCESSES FOR PREPARING OPTICALLY ACTIVE DIAMINE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-02-03 EP disclosed
US-20160016974-A1 PREPARATION METHOD OF OPTICALLY ACTIVE DIAMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-01-21 US disclosed
EP-2907390-A1 CONTROL AGENTS FOR HONEYBEE PARASITES AND CONTROL METHOD FOR HONEYBEE PARASITES USING SAME Meiji Seika Pharma Co., Ltd. (JP) 2015-08-19 EP disclosed
US-20150210640-A1 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2015-07-30 US disclosed
US-9066517-B2 Pest control agents for honeybee parasitic pests, and pest control method for honeybee parasitic pests using the pest control agents MEIJI SEIKA PHARMA CO., LTD. (JP) 2015-06-30 US disclosed
EP-2876105-A1 1-(CYCLOALKYL-CARBONYL)PROLINE DERIVATIVE Sumitomo Dainippon Pharma Co., Ltd. (JP) 2015-05-27 EP disclosed
EP-2121679-B1 METHOD FOR PRODUCING AZONIASPIRONORTROPINE ESTERS K H S PHARMA HOLDING GMBH (DE) 2015-04-15 EP disclosed
US-20150057288-A1 PEST CONTROL AGENTS FOR HONEYBEE PARASITIC PESTS, AND PEST CONTROL METHOD FOR HONEYBEE PARASITIC PESTS USING THE PEST CONTROL AGENTS MEIJI SEIKA PHARMA CO., LTD. (JP) 2015-02-26 US disclosed
US-20150005347-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 2-IMINO GROUP AND PEST CONTROL AGENT INCLUDING THE SAME MEIJI SEIKA PHARMA CO., LTD. (JP) 2015-01-01 US disclosed
US-20140315839-A1 PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2014-10-23 US disclosed
US-8829208-B2 Process for the preparation of darunavir and darunavir intermediates MAPI PHARMA LTD. (IL) 2014-09-09 US disclosed
US-8808961-B2 Composition, resist film, pattern forming method, and inkjet recording method FUJIFILM CORPORATION (JP) 2014-08-19 US disclosed
EP-1211254-B1 Process for the preparation of benzoxazine derivatives and intermediates therefor DAIICHI SANKYO CO LTD (JP) 2014-05-07 EP disclosed
EP-2284174-B1 Intermediates for the preparation of benzoxazine derivatives and process for their preparation DAIICHI SANKYO CO LTD (JP) 2014-03-05 EP disclosed
EP-2025672-B1 PROCESS FOR PRODUCING 1-CARBAMOYL-3,7-DIOXO-1,4-DIAZEPANE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2013-09-18 EP disclosed
WO-2013129688-A1 PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2013-09-06 WO disclosed
EP-2634174-A2 Nitrogen-containing hetercyclic derivate having 2-imino group and pest control agent including the same Meiji Seika Pharma Co., Ltd. (JP) 2013-09-04 EP disclosed
EP-2633756-A1 Pest control composition including novel iminopyridine derivate Meiji Seika Pharma Co., Ltd. (JP) 2013-09-04 EP disclosed
EP-2360160-B1 Intermediates and their use for producing benzoxazine derivative DAIICHI SANKYO CO LTD (JP) 2013-07-24 EP disclosed
EP-2218722-B9 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI SANKYO CO LTD (JP) 2013-06-19 EP disclosed
EP-2218722-B1 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI SANKYO CO LTD (JP) 2013-03-13 EP disclosed
EP-2528923-A1 PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES Mapi Pharma Limited (IL) 2012-12-05 EP disclosed
US-20120296101-A1 PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES MAPI PHARMA LIMITED (IL) 2012-11-22 US disclosed
EP-2477073-A1 Resist composition for electron beam, EUV or X-ray Fujifilm Corporation (JP) 2012-07-18 EP disclosed
WO-2012063269-A2 PROCESS FOR PREPARING ILOPERIDONE CADILA HEALTHCARE LIMITED (IN) 2012-05-18 WO disclosed
US-8163767-B2 Heterocyclic Janus Kinase 3 inhibitors ASTELLAS PHARMA INC. (JP) 2012-04-24 US disclosed
EP-2130827-B1 METHOD FOR PRODUCING QUINOLONE CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2012-02-01 EP disclosed
US-8049006-B2 7-membered ring compound and method of production and pharmaceutical application thereof DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-11-01 US disclosed
EP-2360160-A1 Intermediates and their use for producing benzoxazine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-08-24 EP disclosed
WO-2011092687-A1 PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES MAPI PHARMA HK LIMITED (CN) 2011-08-04 WO disclosed
US-20110102528-A1 COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2011-05-05 US disclosed
US-20110065926-A1 METHOD OF PREPARING IONIC LIQUIDS BASF SE (DE) 2011-03-17 US disclosed
US-7897806-B2 Reacting primary amines with phosgene in ionic liquid as solvent BASF AKTIENGESELLSCHAFT (DE) 2011-03-01 US disclosed
EP-2284174-A1 INTERMEDIATES FOR THE PREPARATION OF BENZOXAZINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION Daiichi Sankyo Company, Limited (JP) 2011-02-16 EP disclosed
US-7875722-B2 having high antibacterial activity and high safety, at high yield and in a simple manner; one-pot process DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-01-25 US disclosed
US-7858802-B2 Method of preparing ionic liquids BASF SE (DE) 2010-12-28 US disclosed
EP-2251341-A1 Heterocyclic Janus kinase 3 inhibitors Astellas Pharma Inc. (JP) 2010-11-17 EP disclosed
EP-2218722-A2 Process for producing benzoxazine derivative and production intermediate thereof Daiichi Sankyo Company, Limited (JP) 2010-08-18 EP disclosed
US-20100191010-A1 PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 HUNTSMAN INTERNATIONAL LLC (US) 2010-07-29 US disclosed
EP-1435357-B1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives BASILEA PHARMACEUTICA AG (CH) 2010-03-17 EP disclosed
US-20100063279-A1 METHOD FOR PRODUCING QUINOLONE CARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-03-11 US disclosed
US-20100048903-A1 Method For Producing Azoniaspironortropine Esters And Nortropan-3-One Compounds K.H.S. PHARMA HOLDING GMBH (DE) 2010-02-25 US disclosed
EP-1448567-B1 METHOD FOR THE PREPARATION OF HEXAHYDRO-FURO 2,3-B FURAN-3-OL TIBOTEC PHARM LTD (IE) 2009-12-30 EP disclosed
EP-2130827-A1 METHOD FOR PRODUCING QUINOLONE CARBOXYLIC ACID DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-12-09 EP disclosed
EP-2121679-A1 METHOD FOR PRODUCING AZONIASPIRONORTROPINE ESTERS AND NORTROPAN-3-ONE COMPOUNDS K.H.S. Pharma Holding Gmbh (DE) 2009-11-25 EP disclosed
US-7612166-B2 Fluorous capping reagents and methods for peptide purification TRUSTEES OF TUFTS COLLEGE (US) 2009-11-03 US disclosed
US-20090264399-A1 HETEROCYCLIC JANUS KINASE 3 INHIBITORS ASTELLAS PHARMA INC. (JP) 2009-10-22 US disclosed
US-20090253683-A1 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF ASUBIO PHARMA CO., LTD (JP) 2009-10-08 US disclosed
US-7595408-B2 Methods for the preparation of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol TIBOTEC PHARMACEUTICALS, LTD. (IE) 2009-09-29 US disclosed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US disclosed
US-20090105491-A1 OPTICALLY ACTIVE DIAMINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-04-23 US disclosed
US-7521168-B2 Compound that has a reduction potential higher than that of diphenyl iodonium salt and generates an acid upon irradiation of an actinic ray or radiation. FUJIFILM CORPORATION (JP) 2009-04-21 US disclosed
US-20090098447-A1 RESIN COMPOSITION FOR FUEL CELL SEPARATOR, AND FUEL CELL SEPARATOR NICHIAS CORPORATION (JP) 2009-04-16 US disclosed
EP-2025672-A1 SEVEN-MEMBERED RING COMPOUND, PRODUCTION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF Asubio Pharma Co., Ltd. (JP) 2009-02-18 EP disclosed
EP-2011782-A1 Process for the synthesis of carbamates using co2 HUNTSMAN INTERNATIONAL LLC (US) 2009-01-07 EP disclosed
US-20080275216-A1 Fluorous Capping Reagents and Methods for Peptide Purification TRUSTEES OF TUFTS COLLEGE (US) 2008-11-06 US disclosed
WO-2008101728-A1 METHOD FOR PRODUCING AZONIASPIRONORTROPINE ESTERS AND NORTROPAN-3-ONE COMPOUNDS K.H.S. PHARMA HOLDING GMBH (DE) 2008-08-28 WO disclosed
US-20080200535-A1 sphingosine 1-phosphate-1/EDG-1 receptor agonists; autoimmune diseases; immunosuppressants by inducing lymphocyte sequestration in secondary lymphoid tissues; 4-aminocyclopentane-2-encarboxylic acid hydrochloric acid salt ASAHI KASEI PHARMA CORPORATION (JP) 2008-08-21 US disclosed
EP-1925611-A1 OPTICALLY ACTIVE DIAMINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-05-28 EP disclosed
EP-1910358-A2 HETEROCYCLIC JANUS KINASE 3 INHIBITORS Astellas Pharma Inc. (JP) 2008-04-16 EP disclosed
US-20070208184-A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL Janssen Sciences Ireland Unlimited Company (IE) 2007-09-06 US disclosed
US-20070142646-A1 Method of preparing ionic liquids BASF AKTIENGESELLSCHAFT (DE) 2007-06-21 US disclosed
US-7189847-B2 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-13 US disclosed
WO-2007007919-A2 HETEROCYCLIC JANUS KINASE 3 INHIBITORS ASTELLAS PHARMA INC. (JP) 2007-01-18 WO disclosed
EP-1732931-A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL Tibotec Pharmaceuticals Ltd. (IE) 2006-12-20 EP disclosed
EP-1644395-B1 PROCESSES FOR PREPARING 4'AZIDO NUCLEOSIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-22 EP disclosed
US-20060251961-A1 Use of an ionic liquid BASF AKTIENGESELLSCHAFT (DE) 2006-11-09 US disclosed
US-7126015-B2 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol TIBOTEC PHARMACEUTICALS LTD. (IE) 2006-10-24 US disclosed
EP-1693704-A2 Resist composition and pattern forming method using the same Fuji Photo Film Co., Ltd. (JP) 2006-08-23 EP disclosed
US-7087778-B2 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-08 US disclosed
US-20060172226-A1 Resist composition and pattern forming method using the same FUJI PHOTO FILM CO., LTD. 2006-08-03 US disclosed
US-20060167014-A1 Piperazine compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION 2006-07-27 US disclosed
EP-1644395-A1 PROCESSES FOR PREPARING 4'AZIDO NUCLEOSIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-04-12 EP disclosed
US-20060014947-A1 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. 2006-01-19 US disclosed
WO-2005118527-A2 FLUOROUS CAPPING REAGENTS, AND METHODS FOR PEPTIDE PURIFICATION TRUSTEES OF TUFTS COLLEGE (US) 2005-12-15 WO disclosed
WO-2005095410-A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-10-13 WO disclosed
EP-1029851-B1 PIPERAZINE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2005-04-20 EP disclosed
EP-1289998-B1 NEW PROCESS FOR THE PREPARATION OF VINYL-PYRROLIDINONE CEPHALOSPORINE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2005-03-30 EP disclosed
US-6872823-B1 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-03-29 US disclosed
US-20050038240-A1 Processes for preparing 4'-azido-nucleoside derivatives ROCHE PALO ALTO LLC 2005-02-17 US disclosed
US-20050027119-A1 Process for producing benzoxazine derivative and production intermediate thereof DAIICHI PHARMACEUTICAL CO., LTD. 2005-02-03 US disclosed
WO-2005000864-A1 PROCESSES FOR PREPARING 4’AZIDO NUCLEOSIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-01-06 WO disclosed
US-20040249175-A1 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol Janssen Sciences Ireland Unlimited Company (IE) 2004-12-09 US disclosed
EP-1448567-A1 METHOD FOR THE PREPARATION OF HEXAHYDRO-FURO 2,3-B]FURAN-3-OL Tibotec Pharmaceuticals Ltd. (IE) 2004-08-25 EP disclosed
EP-1435357-A2 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives Basilea Pharmaceutica AG (CH) 2004-07-07 EP disclosed
EP-1027332-B1 NOVEL LACTAM METALLOPROTEASE INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-05-26 EP disclosed
EP-1363890-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2003-11-26 EP disclosed
EP-1338921-A2 Resist composition for electron beam, X-ray or EUV Fuji Photo Film Co., Ltd. (JP) 2003-08-27 EP disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-20030134827-A1 Novel lactam metalloprotease inhibitors DUAN JINGWU (US) 2003-07-17 US disclosed
US-20030055064-A1 Piperazine compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION 2003-03-20 US disclosed
WO-2003022853-A1 METHOD FOR THE PREPARATION OF HEXAHYDRO-FURO[2,3-B]FURAN-3-OL TIBOTEC PHARMACEUTICALS LTD. (IE) 2003-03-20 WO disclosed
EP-1289998-A1 NEW PROCESS FOR THE PREPARATION OF VINYL-PYRROLIDINONE CEPHALOSPORINE DERIVATIVES Basilea Pharmaceutica AG (CH) 2003-03-12 EP disclosed
US-20030018034-A1 Piperazine compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION 2003-01-23 US disclosed
US-6504025-B2 In fewer steps and is obtained in higher yield; chemical intermediates; useful in treating methicillin resistent Staphylococcus aureus and Pseudomonas aeruginosa BASILEA PHARMACEUTICA AG (CH) 2003-01-07 US disclosed
US-6455528-B1 TUMOR NECROSIS FACTOR ANTAGONIST AND/OR INTERLEUKIN PROMOTER; ANTIALLERGENS, ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE TREATMENT MITSUBISHI PHARMA CORPORATION (JP) 2002-09-24 US disclosed
WO-2002062766-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-08-15 WO disclosed
WO-2002059118-A1 PROCESS FOR N-(OXYALKYLATION) OF CARBOXAMIDES SYNGENTA LIMITED (GB) 2002-08-01 WO disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
EP-1211254-A1 PROCESS FOR THE PREPARATION OF BENZOXAZINE DERIVATIVES AND INTERMEDIATES THEREFOR DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-06-05 EP disclosed
EP-1204645-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF Millennium Pharmaceuticals, Inc. (US) 2002-05-15 EP disclosed
US-6372800-B1 IMMUNOSUPPRESSIVE EFFECT AND IS USEFUL AS AN INHIBITOR FOR THE REJECTION REACTION OCCURRING IN ORGAN OR BONE MARROW TRANSPLANTATION, AND AS A PREVENTIVE OR REMEDY FOR ARTICULAR RHEUMATISM, ATOPIC ECZEMA (DERMATITIS), BEHCET'S DISEASE, MITSUBISHI PHARMA CORPORATION (JP) 2002-04-16 US disclosed
US-20020019381-A1 Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2002-02-14 US disclosed
EP-0778263-B1 BENZENE COMPOUND AND MEDICINAL USE THEREOF WELFIDE CORP (JP) 2002-01-09 EP disclosed
WO-2001090111-A1 NEW PROCESS FOR THE PREPARATION OF VINYL-PYRROLIDINONE CEPHALOSPORINE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2001-11-29 WO disclosed
EP-0672718-B1 Polyvinyl alcohol film, process for the production thereof and laminate MITSUBISHI GAS CHEMICAL CO (JP) 2001-06-06 EP disclosed
WO-2001010842-A2 MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2001-02-15 WO disclosed
US-6187821-B1 SUCH AS 2-AMINO-2-(3-(4-HEPTYLPHENYL)PROPYL)BUTANE-1,4-DIOL; IMMUNOSUPPRESSANT; ADMINISTERING TO TREAT OR PREVENT AUTOIMMUNE DISEASES AND ALLERGIES WELFIDE CORPORATION (JP) 2001-02-13 US disclosed
EP-1029851-A1 PIPERAZINE COMPOUNDS AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-08-23 EP disclosed
EP-1027332-A1 NOVEL LACTAM METALLOPROTEASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-08-16 EP disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed
US-6001851-A HIV protease inhibitors AGOURON PHARMACEUTICALS, INC. (US) 1999-12-14 US disclosed
WO-1999018074-A1 NOVEL LACTAM METALLOPROTEASE INHIBITORS Britol-Myers Squibb Pharma Company (US) 1999-04-15 WO disclosed
EP-0778263-A1 BENZENE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-06-11 EP disclosed
US-5582916-A Polyvinyl alcohol film, process for the production thereof and laminate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1996-12-10 US disclosed
EP-0672718-A1 Polyvinyl alcohol film, process for the production thereof and laminate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-09-20 EP disclosed
EP-0269042-B1 PROCESS FOR PREPARING 2 PROPENYLIDENE-3 ETHYL GLUTARIC ACID DIESTERS BASF Aktiengesellschaft (DE) 1991-10-16 EP disclosed
US-4889911-A ESTERIFICATION, ESTER INTERCHANGE; CATALYSIS WITH HETEROCYCLIC NITROGEN COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1989-12-26 US disclosed
US-4886869-A OPTIONALLY SUBSTITUTED WITH-3-HYDROXY BENZOIC ACID; RIGIDITY, IMPACT STRENGTH AND ELONGATION BAYER AKTIENGESELLSCHAFT (DE) 1989-12-12 US disclosed
EP-0303931-A2 Process for the fabrication of thermotropic, wholly aromatic polyesters and polyestercarbonates BAYER AG (DE) 1989-02-22 EP disclosed
EP-0303935-A2 Thermotropic, aromatic polyestercarbonates, a process for their fabrication and their use BAYER AG (DE) 1989-02-22 EP disclosed
EP-0269042-A2 Process for preparing 2 propenylidene-3 ethyl glutaric acid diesters BASF Aktiengesellschaft (DE) 1988-06-01 EP disclosed
EP-0269042-A2 Process for preparing 2 propenylidene-3 ethyl glutaric acid diesters BASF Aktiengesellschaft (DE) 1988-06-01 EP disclosed